Clinical trials: Bladder Cancer Requiring Cystectomy
Bladder Cancer Requiring Cystectomy
Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial
This is a multi-institutional, randomized trial evaluating oncologic, perioperative, and functional outcomes following two standard care procedures for radical cystectomy.
- Trial name
- NCT01157676
- Testing
- Open radical cystectomy, Robotic assisted radical cystectomy, DaVinci robot
- Where
- 16 sites in United States
- Volunteers
- 350 people
- Sponsor
- University of Miami
Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer
This phase II trial studies how well erlotinib hydrochloride works in Treating participants with muscle invasive urothelial cancer or urothelial cancer that has come back.
- Conditions
- Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma, Recurrent Urethral Urothelial Carcinoma
- Trial name
- NCT00749892
- Testing
- Erlotinib Hydrochloride
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- M.D. Anderson Cancer Center